Doheny Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California 90033, USA.
Invest Ophthalmol Vis Sci. 2012 Feb 21;53(2):897-905. doi: 10.1167/iovs.11-8297. Print 2012 Feb.
To characterize antigen-specific and bystander IL-17+ T cells induced in immunized mice.
C57BL/6 (B6) mice were immunized with the uveitogenic peptide IRBP₁₋₂₀ in either incomplete (IFA) or complete (CFA) Freund's adjuvant. In vivo-primed T cells were stimulated with syngeneic APCs, with or without the immunizing peptide, under polarizing conditions. Activated T cells were analyzed for expression and production of IL-17.
B6 mice immunized with the uveitogenic peptide IRBP₁₋₂₀ generated two types of IL-17+ T cell: one specific for the immunizing autoantigen (IRBP-Th17) and a much more abundant type (bystander-Th17) that is not reactive with the immunizing antigen. The bystander-Th17 can be demonstrated when in vivo-primed T cells are cultured in Th17-polarizing conditions in the absence of antigen stimulation. Increased expansion of both types of Th17 cells was seen in mice immunized with IRBP₁₋₂₀/CFA, but not with IRBP₁₋₂₀/IFA. Both T-cell types produced IL-17, IL-22, and IFN-γ, but only bystander Th17 cells produced IL-10. Addition to culture medium of IL-6 and TGF-β1 caused more activation of bystander-Th17 T cells than IRBP-Th17 cells. When adoptively transferred into syngeneic naïve mice, the bystander-Th17 cells neutralized the pathogenic activity of the IRBP-Th17 cells.
A procedure commonly used to induce autoimmune disease promotes two functionally antagonistic types of IL-17+ T cells, and the pathogenic type is restricted to the population that specifically responds to the immunizing autoantigen. Molecular components of the CFA, rather than the immunizing peptide, promote the generation of both types of IL-17+ T cells.
描述在免疫小鼠中诱导的抗原特异性和旁观者 IL-17+T 细胞的特征。
用致葡萄膜炎肽 IRBP₁₋₂₀ 在不完全(IFA)或完全(CFA)弗氏佐剂中免疫 C57BL/6(B6)小鼠。用或不用免疫肽,在极化条件下,用同种异体 APC 刺激体内初始 T 细胞。分析激活的 T 细胞表达和产生 IL-17 的情况。
用致葡萄膜炎肽 IRBP₁₋₂₀ 免疫的 B6 小鼠产生了两种类型的 IL-17+T 细胞:一种对免疫原性自身抗原特异(IRBP-Th17),另一种更丰富的类型(旁观者-Th17),不与免疫原性抗原反应。当体内初始 T 细胞在缺乏抗原刺激的情况下在 Th17 极化条件下培养时,可以证明旁观者-Th17 的存在。在用 IRBP₁₋₂₀/CFA 免疫的小鼠中,两种类型的 Th17 细胞均有增加的扩增,但在用 IRBP₁₋₂₀/IFA 免疫的小鼠中则没有。两种 T 细胞类型均产生 IL-17、IL-22 和 IFN-γ,但只有旁观者 Th17 细胞产生 IL-10。在培养物中添加 IL-6 和 TGF-β1 会引起旁观者-Th17 细胞比 IRBP-Th17 细胞更多的激活。当被过继转移到同种异体 naive 小鼠中时,旁观者-Th17 细胞中和了 IRBP-Th17 细胞的致病性活性。
一种常用于诱导自身免疫性疾病的方法促进了两种具有不同功能的 IL-17+T 细胞类型,而致病性类型仅限于特异性应答免疫原性自身抗原的细胞群。CFA 的分子成分而不是免疫肽,促进了两种类型的 IL-17+T 细胞的产生。